Completed PHASE4 INTERVENTIONAL 1-arm NCT00199082

Newly Diagnosed Mature B-ALL, Burkitt's Lymphoma and Other High-grade Lymphoma in Adults

Multicenter Study to Optimise Therapy of B-ALL, Burkitt's NHL and High-Grade Non-Hodgkin's Lymphoma in Adults (Amend 7)

Sponsor: Nicola Goekbuget

Conditions Burkitt's Leukemia Burkitt's Lymphoma Large Cell Anaplastic Lymphoma Lymphoblastic Lymphoma Mediastinal Neoplasms

Interventions Adriamycin Cyclophosphamide Cytarabine Dexamethasone/Prednisolone G-CSF Ifosfamide Irradiation (in specific conditions) Methotrexate Rituximab VP16 Vincristine/Vindesine

Updated 7 times since 2017 Last updated: Aug 17, 2022 Started: Jul 31, 2002 Primary completion: Jun 30, 2010 Completion: Jun 30, 2010

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00199082, this PHASE4 trial focuses on Burkitt's Leukemia and Burkitt's Lymphoma and remains completed. Sponsored by Nicola Goekbuget, it has been updated 7 times since 2002, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Change History

7 versions recorded

Jan 2026 — Present [monthly]

Completed PHASE4
Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Sep 2022 — Jul 2024 [monthly]

Completed PHASE4
Jan 2021 — Sep 2022 [monthly]

Completed PHASE4

▶ Show 2 earlier versions

Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Jul 2002

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Nicola Goekbuget

Data source: Goethe University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Frankfurt, Germany